4142:TPE
Adimmune Corp
NT$ १६.१५
arrow_downward
-०.६२%(-०.१०) 1D
नोभेम्बर १८, १३:३०:०२ GMT+८ · TWD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4142...
Open
NT$ १६.३५
High
NT$ १६.५५
Low
NT$ १६.००
Mkt. cap
६.९४ अरब
Avg. vol.
१०.९४ लाख
Volume
५.३५ लाख
52-wk high
NT$ २१.५०
52-wk low
NT$ १५.६५
EPS
-NT$ ०.३४
Shares outstanding
२३.५३ करोड
No. of employees
५६४
Open
NT$ १६.३५
High
NT$ १६.५५
Low
NT$ १६.००
Mkt. cap
६.९४ अरब
Avg. vol.
१०.९४ लाख
Volume
५.३५ लाख
52-wk high
NT$ २१.५०
52-wk low
NT$ १५.६५
EPS
-NT$ ०.३४
Shares outstanding
२३.५३ करोड
No. of employees
५६४
News stories
From web sources and news partners
TradingView
·
२ घण्टा पहिले
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of FOMC Minutes— NVDA, AAOI, PANW in Focus (UPDATED)
San Luis Obispo Tribune
·
१ घण्टा पहिले
S&P 500, Nasdaq open higher as Nvidia forecast eases AI jitters
CNBC
·
४० मिनेट पहिले
The key S&P 500 level Wall Street is watching
FOREX.com
·
४ घण्टा पहिले
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Profile
Adimmune Corporation is a Taiwanese pharmaceutical company engaged in the research, development, manufacturing, and sales of medicines and vaccines for both humans and animals. Its products are supplied to both local and international markets.
Founded in 1965 and headquartered in Tanzi District, Taichung, it has a market cap of US$230 million, 564 employees and annual sales of $106 million as of 2026.
Adimmune continues to seek expansion its role in the regional pharmaceutical and vaccine industry through international collaborations.
In January 2021, Adimmune Corporation announced a partnership with Sam Chun Dang Pharm to jointly develop an injectable medication used to treat macular disease.
In July 2021, the company announced that its first overseas manufacturing site will be situated in the Special Economic Zone in East Java, Indonesia, aiming to launch clinical trials for its COVID-19 vaccine in Indonesia early 2022.
In August 2021, Adimmune Corporation signed a memorandum of understanding with Becton, Dickinson and Company to strengthen its international pharmaceutical collaboration. Wikipedia
About Adimmune Corp